Infliximab for the treatment of refractory scleritis

BACKGROUND: Scleritis is a potentially blinding inflammatory disorder. Standard care consists of systemic corticosteroids and immunosuppresants. The authors describe a series of 10 patients suffering from scleritis treated with the TNF inhibitor infliximab because this scleritis was refractory to st...

Descripción completa

Detalles Bibliográficos
Autores principales: Doctor, Priyanka, Sultan, Amyna, Syed, Sana, Christen, William, Bhat, Pooja, Foster, C Stephen
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2009
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2976470/
https://www.ncbi.nlm.nih.gov/pubmed/19955205
http://dx.doi.org/10.1136/bjo.2008.150961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2976470/
https://www.ncbi.nlm.nih.gov/pubmed/19955205
http://dx.doi.org/10.1136/bjo.2008.150961

Ejemplares similares